Home/NovaBiotics/Dr. Deborah O'Neil
DD

Dr. Deborah O'Neil

Founder, Chief Executive Officer & Scientific Officer

NovaBiotics

NovaBiotics Pipeline

DrugIndicationPhase
NM001Cystic FibrosisPhase 2
NM002Cystic Fibrosis / Respiratory ConditionsClinical
Cysteamine BitartrateMycobacterial Disease (e.g., Tuberculosis)Pre-clinical/Research
Tinexyl PROToenail Health (Dystrophic/Fungal)Commercial